Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute promyelocytic leukemia: where does it stem from?

D Grimwade1, T Enver

  • 1Department of Medical and Molecular Genetics, Guy's, King's and St Thomas' School of Medicine, London, UK. david.grimwade@kcl.ac.uk

Leukemia
|January 23, 2004
PubMed
Summary

Acute myeloid leukemia (AML) arises from primitive stem cells. Acute promyelocytic leukemia (APL) may originate from multiple cell types, resolving conflicting evidence and informing treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Mir142 loss unlocks IDH2<sup>R140</sup>-dependent leukemogenesis through antagonistic regulation of HOX genes.

Scientific reports·2021
Same author

Mir142 loss unlocks IDH2<sup>R140</sup>-dependent leukemogenesis through antagonistic regulation of HOX genes.

Scientific reports·2020
Same author

Author Correction: Osmotic modulation of chromatin impacts on efficiency and kinetics of cell fate modulation.

Scientific reports·2018
Same author

Osmotic modulation of chromatin impacts on efficiency and kinetics of cell fate modulation.

Scientific reports·2018
Same author

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017
Same author

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia.

Leukemia·2017

Area of Science:

  • Cancer Biology
  • Hematology
  • Molecular Oncology

Background:

  • Acute myeloid leukemia (AML) is characterized by the transformation of primitive stem cells.
  • Cancer stem cells (CSCs) maintain the leukemic clone through self-renewal.
  • The cellular origin of acute promyelocytic leukemia (APL) remains unclear, with conflicting data suggesting it arises from differentiated myeloid progenitors.

Purpose of the Study:

  • To review conflicting evidence regarding the cellular origins of Acute Promyelocytic Leukemia (APL).
  • To propose a model where APL may originate from multiple cellular compartments.
  • To discuss the implications of APL's cellular origin for biological mechanisms and clinical treatment.

Main Methods:

  • Literature review of existing studies on AML and APL cellular origins.
  • Analysis of conflicting experimental data.
  • Synthesis of evidence to propose a unifying model for APL pathogenesis.

Main Results:

  • Evidence suggests that while AML generally originates from primitive stem cells, APL might arise from more than one cell type.
  • This multi-compartment origin model reconciles inconsistencies in previous APL research.
  • The self-renewal capacity of CSCs is crucial for maintaining the leukemic clone in AML.

Conclusions:

  • Acute promyelocytic leukemia (APL) may originate from multiple cellular compartments, not solely committed myeloid progenitors.
  • Understanding the specific target cell in APL is critical for advancing treatment strategies.
  • This revised understanding of APL's cellular basis has significant implications for cancer biology and therapy.

Related Experiment Videos